Novel human protease inhibitor and polynucleotides encoding the same

• US 20050260726A1
• Filed: 03/31/2005
• Published: 11/24/2005
• Est. Priority Date: 12/18/2000
• Status: Abandoned Application

• Current Assignee: Boris Nepomnichy, Walke D. Wade, Yi Hu
• Original Assignee: Boris Nepomnichy, Walke D. Wade, Yi Hu
• Inventors: Hu, Yi, Walke, D. Wade, Nepomnichy, Boris
• Application Number:
  US11/096,276
• Publication Number:
  US 20050260726A1
• Time in Patent Office: Days
• US Class Current: 435/184
• CPC Class Codes: A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
• CPC Class Codes: C07K 14/47 from mammals
• CPC Class Codes: C07K 14/8107 Endopeptidase (E.C. 3.4.21-99) inhibitors
• CPC Class Codes: C07K 14/8121 Serpins

Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.

Claims

1-4. -4. (canceled)

5. A gene delivery system comprising a nucleic acid molecule comprising at least 100 contiguous bases of the nucleic acid sequence described in SEQ ID NO:

1.

6. The gene delivery system of claim 5, wherein said isolated nucleic acid molecule is present in a viral vector.

7. The gene delivery system of claim 5, wherein said isolated nucleic acid molecule is present in a cationic lipid complex.

8. An antibody having immunospecificity for the polypeptide sequence of SEQ ID NO:

2.